利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

50 条记录 (耗时 0.026 秒)

    Image display system, image display apparatus and peripheral devices of image display apparatus
    32.
    发明授权
    Image display system, image display apparatus and peripheral devices of image display apparatus 有权
    图像显示系统，图像显示装置和图像显示装置的外围设备

    公开(公告)号：US07034902B2

    公开(公告)日：2006-04-25

    申请号：US09941592

    申请日：2001-08-30

    申请人： Hisao Tajima

    发明人： Hisao Tajima

    IPC分类号： H04N5/64

    CPC分类号： G06F1/1601 ,  G06F1/1605 ,  G06F1/1607 ,  G06F2200/1612 ,  H04N5/64 ,  H04N5/642 ,  Y10S248/918

    摘要： An image display system has an image display apparatus and a peripheral device that can be mounted on the image display apparatus. The image display apparatus includes a first electrode for electrically connecting the image display apparatus and peripheral device, and the peripheral device includes a second electrode for electrically connecting the image display apparatus and peripheral device. These electrodes are placed so as to have contact with one another when the peripheral device is mounted on the image display apparatus. In addition, the image display system moves the mounting position of the peripheral device on the image display apparatus as appropriate. The system minimizes cables used for electrical connections between the image display apparatus and peripheral devices, makes the apparatus compact and allows adoption of a variety of layouts.

    摘要翻译： 图像显示系统具有能够安装在图像显示装置上的图像显示装置和外围装置。 图像显示装置包括用于电连接图像显示装置和外围装置的第一电极，并且外围装置包括用于电连接图像显示装置和外围装置的第二电极。 当外围设备安装在图像显示装置上时，这些电极被放置成彼此接触。 此外，图像显示系统适当地移动图像显示装置上的外围设备的安装位置。 该系统最小化了用于图像显示设备和外围设备之间的电气连接的电缆，使设备紧凑并允许采用各种布局。

    Carboxylic acid derivatives and drugs containing the same as the active ingredient
    34.
    发明授权
    Carboxylic acid derivatives and drugs containing the same as the active ingredient 失效
    羧酸衍生物和含有与活性成分相同的药物

    公开(公告)号：US06664281B1

    公开(公告)日：2003-12-16

    申请号：US09763575

    申请日：2001-02-26

    申请人： Hisao Tajima ,  Yoshisuke Nakayama ,  Daikichi Fukushima

    发明人： Hisao Tajima ,  Yoshisuke Nakayama ,  Daikichi Fukushima

    IPC分类号： C07D26332

    CPC分类号： C07D413/04 ,  C07D263/32 ,  C07D493/08

    摘要： A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diabetes or syndrome X.

    摘要翻译： 含有式（I）的羧酸衍生物（其中所有符号如本说明书中所定义），其无毒性酸或其水合物作为活性成分的过氧化物酶体增殖物激活受体调节剂。由于具有调节PPAR的作用 ，式（I）化合物可用作降血糖药，降血脂药，与代谢紊乱相关疾病（糖尿病，肥胖症，综合征X，高胆固醇血症，高脂蛋白血症等），高脂血症，动脉粥样硬化的预防和/或补救措施 高血压，循环系统疾病，暴饮暴食，冠心病等，HDL胆固醇升高剂，LDL胆固醇和/或VLDL胆固醇降低剂以及用于缓解糖尿病或综合征X危险因素的药物。

    Panel support structure, display panel supported by panel support structure, and image forming apparatus using display panel
    35.
    发明授权
    Panel support structure, display panel supported by panel support structure, and image forming apparatus using display panel 失效
    面板支撑结构，由面板支撑结构支撑的显示面板，以及使用显示面板的图像形成装置

    公开(公告)号：US06494429B2

    公开(公告)日：2002-12-17

    申请号：US09127977

    申请日：1998-08-03

    申请人： Hisao Tajima

    发明人： Hisao Tajima

    IPC分类号： A47F114

    CPC分类号： G09F15/00 ,  G09F7/18 ,  Y10S248/903 ,  Y10S248/918

    摘要： A panel support structure for supporting a flat display panel capable of reducing the weight of the panel support structure while a sufficient structural strength is maintained and capable of preventing the display performance of the flat display panel from being lowered by a change in an ambient temperature. A flat display panel is fixedly supported by an X-character shaped supporting member via dampers fitted in the four corners of the flat display panel by the flat panel fixing parts of the supporting member. The supporting member is disposed along diagonal lines extending between the four corners of the flat display panel and has a rectangular cross section whose longer side is directed in the thickness direction of the flat display panel.

    摘要翻译： 一种用于支撑平板显示面板的面板支撑结构，其能够在保持足够的结构强度的同时减小面板支撑结构的重量，并且能够通过环境温度的变化来防止平板显示面板的显示性能降低。 平板显示面板通过由平板显示面板的四个角落中的阻尼器由支撑构件的平板固定部分固定地支撑在X字形支撑构件上。 支撑构件沿着在平面显示面板的四个角之间延伸的对角线布置，并且具有矩形横截面，其长边在平板显示面板的厚度方向上指向。

    Polypeptide of protein p140 and DNAs encoding it
    38.
    发明授权
    Polypeptide of protein p140 and DNAs encoding it 失效
    蛋白质p140的多肽和编码它的DNA

    公开(公告)号：US5506205A

    公开(公告)日：1996-04-09

    申请号：US348143

    申请日：1994-11-23

    申请人： Hisao Tajima ,  Koichiro Kitagawa ,  Hiroyuki Ohno

    发明人： Hisao Tajima ,  Koichiro Kitagawa ,  Hiroyuki Ohno

    IPC分类号： A61K38/00 ,  C07K14/47 ,  C12N1/21 ,  C12N15/12 ,  C12P21/08 ,  C07K14/435 ,  C12N9/12

    CPC分类号： C07K14/47 ,  A61K38/00

    摘要： The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector comprising the DNA; host cells transformed with the vector; antibody against the polypeptide; pharmaceutical compositions containing the peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylate protein p140, as active ingredient and screening methods for the prevention and/or treatment agent.Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only to improves the diabetes-derived hyperglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).

    摘要翻译： 本发明涉及胰岛素信号传递系统中涉及的关键蛋白质的新型蛋白质p140多肽， 制备方法 编码所述多肽的DNA; 包含DNA的载体; 宿主细胞用载体转化; 抗多肽抗体; 含有肽或抗体的药物组合物; 用于预防和/或治疗糖尿病的方法，其特征在于所述蛋白质p140的酪氨酸磷酸化; 用于预防和/或治疗糖尿病的药物，其特征在于含有可将酪氨酸磷酸化蛋白质p140的化合物作为活性成分和预防和/或治疗剂的筛选方法。 蛋白质p140的酪氨酸磷酸化是通过葡萄糖摄取诱导低血糖的关键步骤。 基于本发明的蛋白质p140的酪氨酸磷酸化的预防和/或治疗方法和药剂不仅可改善糖尿病来源的高血糖病症，而且可用于治疗和/或预防糖尿病，特别是非胰​​岛素依赖性 糖尿病（NIDDM）。

    Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
    39.
    发明授权
    Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient 失效
    羧酸衍生物和含有该衍生物作为活性成分的药物组合物

    公开(公告)号：US07241784B2

    公开(公告)日：2007-07-10

    申请号：US10464459

    申请日：2003-06-19

    申请人： Hisao Tajima ,  Yoshisuke Nakayama ,  Daikichi Fukushima

    发明人： Hisao Tajima ,  Yoshisuke Nakayama ,  Daikichi Fukushima

    IPC分类号： A61K31/422 ,  C07D413/10

    CPC分类号： C07D413/04 ,  C07D263/32 ,  C07D493/08

    摘要： A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from, risk factors of diabetes or syndrome X.

    摘要翻译： 含有式（I）的羧酸衍生物（其中所有符号如说明书中所定义），其无毒性酸或其水合物作为活性成分的过氧化物酶体增殖物激活受体调节剂。 由于具有调节PPAR的作用，式（I）化合物可用作降血糖剂，​​降血脂药，用于代谢紊乱（糖尿病，肥胖症，综合征X，高胆固醇血症，高脂蛋白血症）的疾病的预防和/或补救措施 等），高脂血症，动脉粥样硬化，高血压，循环系统疾病，暴饮暴食，冠心病等，HDL胆固醇升高剂，LDL胆固醇和/或VLDL胆固醇降低剂和用于缓解危险因素的药物 的糖尿病或综合症。

    Phenylacetic acid derivative, process for producing the same, and use
    40.
    发明申请
    Phenylacetic acid derivative, process for producing the same, and use 失效
    苯乙酸衍生物，其制备方法及用途

    公开(公告)号：US20070105868A1

    公开(公告)日：2007-05-10

    申请号：US10572937

    申请日：2004-09-21

    申请人： Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Takahiko Sakamoto

    发明人： Shinya Kusuda ,  Yoshisuke Nakayama ,  Hisao Tajima ,  Takahiko Sakamoto

    IPC分类号： A61K31/496 ,  A61K31/4709 ,  A61K31/454 ,  A61K31/427 ,  A61K31/426

    CPC分类号： C07D413/10 ,  A61K31/421 ,  A61K31/422 ,  A61K31/426 ,  A61K31/4439 ,  A61K31/454

    摘要： The present invention relates to the compound represented by formula (I) (wherein R1 and R2 is hydrogen atom, C1-8 alkyl etc.; R3 is C1-8 alkyl which may be substituted with 1 to 3 halogen atom(s), phenyl; R4 is hydrogen atom etc.; R5 and R6 is hydrogen atom, C1-8 alkyl etc.; X is sulfur atom or oxygen atom etc.; ringA is cyclic group which may have a substituent(s).), or a salt thereof. Toxicity of the compound represented by formula (I) is very low, and it is safe enough to use as a pharmaceutical agent and since it has PPAR δ agonistic activity, it is useful as preventive and/or therapeutic agent for glucose.lipid metabolic disorder, hypertension, circulatory diseases etc.

    摘要翻译： 本发明涉及由式（I）表示的化合物（其中R 1和R 2是氢原子，C 1-8烷基等; R 3 可以被1至3个卤素原子取代的C 1-8烷基，苯基; R 4是氢原子等; R 5和 R 6是氢原子，C 1-8烷基等; X是硫原子或氧原子等;环A是可以具有取代基的环状基团）或其盐。 由式（I）表示的化合物的毒性非常低，并且作为药物使用是安全的，并且由于其具有PPARδ激动活性，因此它可用作葡萄糖脂代谢紊乱的预防和/或治疗剂 ，高血压，循环系统疾病等